Humana (HUM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on November 7. Analyst Whit Mayo ...

Humana reported a $480 million profit and higher-than-expected growth of its Medicare Advantage business that has been hit with higher costs.

Cigna Group has revived efforts to combine with its smaller rival Humana Inc. after merger talks fell apart late last year, according to people familiar with the matter. The two health insurance ...

TD Cowen analyst Ryan Langston maintained a Hold rating on Humana (HUM – Research Report) today and set a price target of $268.00. Ryan ...

Humana Inc. HUM posted third-quarter 2024 adjusted earnings per share (EPS) of $4.16, which surpassed the Zacks Consensus ...

Humana (HUM) stock in focus as company raises MA membership guidance with its Q3 2024 resuls despite setbacks this year. Read ...

The remarks on a call with analysts signaled Cigna is focused on returning cash to shareholders rather than a possible deal ...

There has been speculation of a massive merger in the medical sector between two massive health insurers. Specifically, the ...

Humana (NYSE:HUM) increased its annual membership ... Meanwhile, in line with consensus, the company’s benefits expense ratio, the share of premiums paid out for medical expenses, rose to ...

While the top- and bottom-line numbers for Humana (HUM) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare ...